-
Annexin V-Cy5/DAPI Apoptosis Kit Workflow
2026-09-17
Turn phosphatidylserine exposure and membrane integrity into a fast, two-parameter cell-death profile. This workflow shows how to apply the Annexin V-Cy5/DAPI Apoptosis Kit to Ph+ ALL drug-response studies, mechanism testing, and practical troubleshooting.
-
IL-12 and the Next Frontier in Anti-MRSA Translation
2026-09-17
YZ462 reframes anti-MRSA discovery around membrane vulnerability, permeability, oxidative stress, biofilm biology, and cardiolipin engagement. This thought-leadership perspective translates those findings into a practical research strategy and shows how Recombinant Human IL-12 can be positioned as a controlled host-response variable without overstating evidence for combination therapy.
-
Sulfo-Cy3 Azide for Mapping Nurr1 Neurons
2026-09-16
A mechanistic and translational framework for using Sulfo-Cy3 azide in aqueous Click Chemistry fluorescent labeling, with emphasis on Nurr1-positive neuron development, assay design, and reproducible neuroanatomical imaging.
-
RIPA Lysis Buffer Strong: Assay Design Guide
2026-09-16
RIPA Lysis Buffer Strong can deliver broad protein solubilization, but its value depends on matching detergent strength, inhibitor timing, and assay chemistry. This guide connects RIPA-based extraction decisions with lessons from a mechanistically rigorous cancer metastasis study.
-
Ceftolozane/Tazobactam: Mechanism and Clinical Evidence
2026-09-15
The reference review explains why pairing the antipseudomonal cephalosporin ceftolozane with the β-lactamase inhibitor tazobactam expands activity against important resistant Gram-negative pathogens. Its integrated analysis of mechanism, pharmacokinetics, pharmacodynamics, clinical trials, resistance, and safety provides a practical framework for interpreting this combination in complicated intraabdominal and urinary tract infections.
-
Resveratrol, Smad Signaling, and GBM Invasion
2026-09-15
The 2019 reference study shows that resveratrol suppresses TGF-β1-induced epithelial–mesenchymal transition, migration, invasion, and stem-like behavior in glioblastoma models through Smad-dependent signaling. Its experimental framework links pathway inhibition to measurable changes in tumor-cell plasticity and provides a useful basis for evaluating more selective TGF-β signaling interventions.
-
Imaging Nurr1 Development with Sulfo-Cy3 Azide
2026-09-14
A translational framework for using Sulfo-Cy3 azide in aqueous Click Chemistry fluorescent labeling workflows that map Nurr1-positive developmental territories while preserving biological context, imaging quality, and assay reproducibility.
-
Benzyl-activated Streptavidin Magnetic Beads Guide
2026-09-14
Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) capture biotinylated targets through surface streptavidin and support rapid magnetic separation. The product specifications define a 3 μm, low-charge bead supplied at 10 mg/mL, while the cited annexin-V study provides biological context for isolating or analyzing biotinylated cell-death probes.
-
Cediranib (AZD2171) In Vitro Assay Guide
2026-09-13
Learn how to use Cediranib (AZD2171) to separate VEGFR signaling effects from delayed growth inhibition and cell death in cancer research. This workflow combines pathway-focused phosphoprotein analysis with orthogonal viability measurements for more interpretable angiogenesis experiments.
-
Temafloxacin Pharmacokinetics: 1991 Review
2026-09-12
This 1991 review integrates oral and intravenous pharmacokinetic data to explain how temafloxacin absorption, distribution, elimination, and renal handling support practical dosing decisions. Its main contribution is a translational interpretation linking exposure and pharmacodynamic considerations with dose frequency, tissue penetration, and renal function.
-
Temafloxacin Against Gram-Negative Bacteria
2026-09-11
Hardy’s overview mapped the in vitro activity of temafloxacin across respiratory, enteric, urogenital, and opportunistic Gram-negative pathogens, using ciprofloxacin and ofloxacin as comparators. Its most useful contribution is a differentiated susceptibility profile: strong activity against many respiratory organisms and Enterobacteriaceae, but weaker activity against Pseudomonas aeruginosa than ciprofloxacin.
-
Cinoxacin Workflows for Gram-Negative Research
2026-09-11
Cinoxacin provides a practical quinolone antibiotic model for connecting DNA synthesis inhibition with susceptibility testing, urinary tract infection research, and exposure-aware assay design. This guide emphasizes reproducible MIC and time-kill workflows, spectrum-aware organism selection, and troubleshooting for resistance and solvent-related artifacts.
-
DiscoveryProbe FDA-approved Drug Library for OA
2026-09-10
Translate the OSCAR–PPARγ osteoarthritis finding into a reproducible repositioning workflow with 2,320 clinically established compounds. This guide combines target-focused screening, orthogonal validation, plate-level controls, and troubleshooting for faster identification of disease-modifying candidates.
-
Deferasirox Fe3+ Chelate: Assay Workflows
2026-09-10
Deferasirox Fe3+ chelate provides a defined ferric coordination species for investigating iron-sensitive stress phenotypes, lysosomal biology, and ferritinophagy. This workflow-focused guide connects the Exjade-related chemical context with the TCF25–V-ATPase pathway while emphasizing controls that prevent confusion between a ferric chelate and the unbound oral chelator.
-
Aztreonam in Resistance Mechanism Research
2026-09-09
Aztreonam is a monocyclic β-lactam antibiotic suited to controlled studies of Gram-negative bacterial physiology, resistance phenotypes, and translational safety signals. This article connects its experimental use with recent evidence on mobile carbapenemase genes in Enterobacter cloacae while providing practical assay and handling guidance.